Phreesia Total Non-Operating Income/Expense 2019-2025 | PHR

Phreesia total non-operating income/expense from 2019 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Phreesia Annual Total Non-Operating Income/Expense
(Millions of US $)
2025 $2
2024 $1
2023 $1
2022 $-1
2021 $-2
2020 $-7
2019 $-6
2018 $-4
Phreesia Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2025-01-31 $2
2024-10-31 $0
2024-07-31 $0
2024-04-30 $0
2024-01-31 $-1
2023-10-31 $0
2023-07-31 $1
2023-04-30 $1
2023-01-31 $2
2022-10-31 $0
2022-07-31 $0
2022-04-30 $0
2022-01-31 $0
2021-10-31 $0
2021-07-31 $0
2021-04-30 $0
2021-01-31 $0
2020-10-31 $0
2020-07-31 $0
2020-04-30 $-1
2020-01-31 $-1
2019-10-31 $0
2019-07-31 $-3
2019-04-30 $-2
2019-01-31
2018-10-31 $-1
2018-07-31 $-1
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.467B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.020B 52.51
Tempus AI (TEM) United States $8.898B 0.00
Hims & Hers Health (HIMS) United States $7.354B 118.21
Inspire Medical Systems (INSP) United States $4.713B 91.55
IRhythm Technologies (IRTC) United States $3.412B 0.00
Privia Health (PRVA) United States $2.848B 213.46
Enovis (ENOV) United States $1.975B 12.22
Schrodinger (SDGR) United States $1.872B 0.00
Clover Health Investments (CLOV) United States $1.737B 0.00
Omnicell (OMCL) United States $1.464B 31.58
Azenta (AZTA) United States $1.204B 56.04
10x Genomics (TXG) United States $1.011B 0.00
Butterfly Network (BFLY) United States $0.568B 0.00
Fulgent Genetics (FLGT) United States $0.536B 0.00
Talkspace (TALK) United States $0.517B 307.00
Veradigm (MDRX) United States $0.460B 0.00
Standard BioTools (LAB) United States $0.421B 0.00
TruBridge (TBRG) United States $0.389B 0.00
Claritev (CTEV) United States $0.363B 0.00
Health Catalyst (HCAT) United States $0.277B 0.00
Nyxoah SA (NYXH) Belgium $0.209B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
Pulmonx (LUNG) United States $0.194B 0.00
American Well (AMWL) United States $0.114B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
Retrieve Medical Holdings (RMHI) United States $0.085B 0.00
MDxHealth SA (MDXH) Belgium $0.082B 0.00
CareCloud (CCLD) United States $0.077B 3.33
111 (YI) China $0.071B 0.00
P3 Health Partners (PIII) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.059B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Outset Medical (OM) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
MSP Recovery (MSPR) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00